Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: A Patient-Centered Approach to Improve Screening for Side Effects of Second Generation Antipsychotics (SGAs) [NA]
This clinical trial update reports results from a study aimed at improving screening for side effects of second-generation antipsychotics in…
-
CLINICAL_TRIALS trial_result · 2014-09-10Clinical Trial Update: Trial of D-Cycloserine in Schizophrenia [Phase 3]
This entry notes the completion of a Phase 3 trial of D-Cycloserine in schizophrenia, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-09-09Clinical Trial Update: Effects of Eszopiclone on Sleep-dependent Learning in Schizophrenia [NA]
Clinical trial evaluating the effects of eszopiclone on sleep-dependent learning in individuals with schizophrenia; results posted.
-
CLINICAL_TRIALS trial_result · 2014-09-09Clinical Trial Update: Safety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than Aripiprazole [Phase 1]
Phase 1 safety and tolerability study of aripiprazole intramuscular depot in adults with schizophrenia stabilized on other oral antipsychoti…
-
CLINICAL_TRIALS trial_result · 2014-09-08Clinical Trial Update: Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in Schizophrenia [Phase 3]
Phase 3 trial evaluating whether adding tropisetron to risperidone improves cognitive and perceptual disturbances in schizophrenia; results …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-09-08Clinical Trial Update: Trial of Nicotine Nasal Spray as an Aid for Smoking Cessation in Schizophrenia [Phase 4]
Phase 4 trial evaluating nicotine nasal spray for smoking cessation in schizophrenia has completed. Results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-09-05Clinical Trial Update: Using D-cycloserine to Enhance the Benefits of Cognitive Behavioral Therapy for Schizophrenia [Phase 4]
A Phase 4 trial evaluating D-cycloserine as an adjunct to cognitive behavioral therapy for schizophrenia has completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2014-08-29Clinical Trial Update: How Can Rehospitalisations of Patients With Schizophrenia be Avoided? A Comparison Between Different Compliance Programs [NA]
This entry notes a completed study that compared different compliance programs to reduce rehospitalisations in patients with schizophrenia a…
-
FDA approval · 2014-08-25FDA Approved: INVEGA SUSTENNA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVEGA SUSTENNA (paliperidone palmitate) from Janssen Pharmaceuticals, Inc., indicating a mo…
-
CLINICAL_TRIALS trial_result · 2014-08-21Clinical Trial Update: Effectiveness of Family Group Interventions for People With Schizophrenia [Phase 2]
Phase 2 clinical trial update evaluating the effectiveness of family group interventions for people with schizophrenia (NCT00940394) has bee…
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: D-cycloserine Augmentation of Cognitive Remediation in Schizophrenia [NA]
Clinical trial of D-cycloserine added to cognitive remediation for schizophrenia has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2014-08-19Clinical Trial Update: Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of Schizophrenia [Phase 4]
Phase 4 clinical trial evaluating the effectiveness of vitamin supplementation for residual symptoms in schizophrenia; results were posted a…
-
FDA approval · 2014-08-15FDA Approved: ABILIFY MAINTENA — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
The FDA approved a supplemental application for ABILIFY MAINTENA (aripiprazole long-acting injectable) submitted by Otsuka America Pharmaceu…
-
FDA approval · 2014-08-15FDA Approved: OLANZAPINE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals Limited's generic olanzapine under an Original Application (ANDA).
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: The Influence of Aerobic Exercise on Cognitive Functioning in Schizophrenia. [NA]
A completed clinical trial evaluates whether aerobic exercise improves cognitive functioning in schizophrenia.
-
CLINICAL_TRIALS trial_result · 2014-08-12Clinical Trial Update: Clinical Symptoms of Schizophrenia and Physical Exercise [NA]
Completed clinical trial evaluating the impact of physical exercise on clinical symptoms in schizophrenia.
-
FDA approval · 2014-08-11FDA Approved: ZYPREXA INTRAMUSCULAR — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for ZYPREXA INTRAMUSCULAR (olanzapine) submitted by Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2014-08-07Clinical Trial Update: Effects of Weekly Dosing of D-cycloserine on Cognitive Function in Individuals With Schizophrenia [Phase 4]
Phase 4 trial evaluating weekly dosing of D-cycloserine for cognitive function in individuals with schizophrenia has completed and posted re…
-
CLINICAL_TRIALS trial_result · 2014-08-06Clinical Trial Update: Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897) [Phase 3]
Phase 3 long-term safety study of flexible-dose asenapine in adolescents with schizophrenia completed; results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-08-06Clinical Trial Update: Folate Supplementation in Schizophrenia [Phase 4]
A Phase 4 clinical trial update reports results from using folate (folic acid) supplementation in individuals with schizophrenia; results we…
-
CLINICAL_TRIALS trial_result · 2014-08-01Clinical Trial Update: A Comparative Study to Evaluate the Evolution of Medication Satisfaction and Adherence in Patients Unsatisfied With Current Oral Atypical Antipsychotics by Switching Medication to Paliperidone Palmitate [Phase 4]
Phase 4 clinical trial evaluating the evolution of medication satisfaction and adherence after switching from current oral atypical antipsyc…
-
CLINICAL_TRIALS trial_result · 2014-07-31Clinical Trial Update: Lurasidone Pediatric Pharmacokinetics Study [Phase 1]
Phase 1 pediatric pharmacokinetics study of lurasidone in children with schizophrenia or autism has completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-07-31Clinical Trial Update: An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia [Phase 1]
An open-label Phase 1 study evaluating intramuscular aripiprazole in individuals with schizophrenia has been completed, with results posted.
-
CLINICAL_TRIALS withdrawal · 2014-07-31Clinical Trial Update: Cardio Risk of Acute Schizophrenia Olanzapine Duke [Phase 4]
A Phase 4 clinical trial evaluating cardiac risk with olanzapine in acute schizophrenia/schizoaffective disorder was withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-07-28Clinical Trial Update: Effects of a Cognitive Rehabilitation Program: a Neurocognitive Study [NA]
A clinical trial evaluating a cognitive rehabilitation program for schizophrenia has completed.